Actualités et vidéos - CRYOLIFE INC.

CryoLife Announces Corporate Rebranding and Changes Name to Artivion Artivion to Host Investor & Analyst Day on March 23, 2022 PR Newswire ATLANTA, Jan. 18, 2022 ATLANTA , Jan. 18, 2022 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and rebranding itself to Artivion, Inc., effective immediately. Derived from the words "aorta", "innovation", and "vision", the company's new name and brand...

CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum PR Newswire ATLANTA, Nov. 9, 2021 ATLANTA , Nov. 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that members of management will host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum on Thursday, November 18, 2021 . Due to the...

CryoLife Reports Third Quarter 2021 Financial Results PR Newswire ATLANTA, Nov. 4, 2021 ATLANTA , Nov. 4, 2021 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Achieved total revenues of $72.2 million in the third quarter 2021 versus $65.1 million in the third quarter of 2020, an increase of 11% on a GAAP basis and 9% on a non-GAAP proforma constant currency basis Net income was $10.6 million , or $0.26 per share, in the third quarter of 2021 Non-GAAP net loss was ($1.2) million ,...

CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2021 Financial Results PR Newswire ATLANTA, Oct. 20, 2021 ATLANTA , Oct. 20, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2021 financial results will be released on Thursday, November 4, 2021 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m....

Anthony Semedo Joins CryoLife Board of Directors PR Newswire ATLANTA, Sept. 22, 2021 ATLANTA , Sept. 22, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today the appointment of Anthony "Tony" Semedo to its Board of Directors effective October 1, 2021 . "We are thrilled to welcome Tony, a leader in the aortic space, to our board of directors," commented Pat Mackin , Chairman, President, and Chief Executive...

CryoLife to Participate in Upcoming Virtual Investor Conferences PR Newswire ATLANTA, Aug. 2, 2021 ATLANTA , Aug. 2, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences. CryoLife's management team will present at the upcoming Canaccord Genuity 41 st Annual Growth Conference on Wednesday, August 11, 2021 . The Company's presentation is...

CryoLife Reports Second Quarter 2021 Financial Results PR Newswire ATLANTA, July 29, 2021 ATLANTA , July 29, 2021 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $76.1 million in the second quarter 2021 versus $53.8 million in the second quarter of 2020, an increase of 42% on a GAAP basis and 35% on a non-GAAP proforma constant currency basis Net loss was ($2.2) million , or ($0.06) per share, in the second quarter of 2021 Non-GAAP net income was $4.8...

CryoLife Announces Sale of PerClot to Baxter PR Newswire ATLANTA, July 29, 2021 ATLANTA , July 29, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has completed the sale of its PerClot product line to a subsidiary of Baxter International, Inc. ("Baxter") (NYSE: BAX ), for up to $60.8 million in cash. Of the $60.8 million , CryoLife will receive up to $45.8 million and Starch Medical, Inc. ("SMI")...

CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results PR Newswire ATLANTA, July 15, 2021 ATLANTA , July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2021 financial results will be released on Thursday, July 29, 2021 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET...

CryoLife to Participate in the UBS Global Healthcare Virtual Conference PR Newswire ATLANTA, May 18, 2021 ATLANTA , May 18, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 . The Company's virtual fireside chat is scheduled to begin at 11:00 a.m. ET . A live webcast of the virtual fireside chat will be...

CryoLife Reports First Quarter 2021 Financial Results PR Newswire ATLANTA, April 29, 2021 ATLANTA , April 29, 2021 /PRNewswire/ -- First Quarter and Recent Business Highlights: Achieved total revenues of $71.1 million in the first quarter 2021 versus $66.4 million in the first quarter of 2020, an increase of 7% on a GAAP basis and 3% on a non-GAAP proforma constant currency basis Net loss was ($3.1) million , or ($0.08) per share, in the first quarter of 2021 Non-GAAP net income was $1.4 million...

CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2021 Financial Results PR Newswire ATLANTA, April 15, 2021 ATLANTA , April 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2021 financial results will be released on Thursday, April 29, 2021 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m....

CryoLife to Participate in 20th Annual Needham Virtual Healthcare Conference PR Newswire ATLANTA, April 7, 2021 ATLANTA , April 7, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 20 th Annual Needham Virtual Healthcare Conference on Wednesday, April 14 , 2021. The Company's virtual fireside chat is scheduled to begin at 8:45 a.m. ET . A live webcast of the virtual...

CryoLife to Participate in Oppenheimer 31st Annual Virtual Healthcare Conference PR Newswire ATLANTA, March 9, 2021 ATLANTA , March 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Oppenheimer 31 st Annual Virtual Healthcare conference on Tuesday, March 16 - 17, 2021. The Company's virtual fireside chat is scheduled to begin at 11:20 a.m. ET on March 16 , 2021. A...

CryoLife Reports Fourth Quarter and Full Year 2020 Financial Results PR Newswire ATLANTA, Feb. 11, 2021 ATLANTA , Feb. 11, 2021 /PRNewswire/ -- Fourth Quarter and Recent Business Highlights: Achieved total revenues of $67.9 million in the fourth quarter 2020 versus $69.7 million in the fourth quarter of 2019 Total revenues decreased 3% on a GAAP basis and 5% on a non-GAAP proforma constant currency basis versus fourth quarter 2019 Excluding TMR, fourth quarter revenues decreased 2% on a non-GAAP...

CryoLife Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2020 Financial Results PR Newswire ATLANTA, Jan. 28, 2021 ATLANTA , Jan. 28, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2020 financial results will be released on Thursday, February 11, 2021 after the market closes. On that day, the Company will hold a teleconference call...

CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020 Webcast to Include Presentation by Steering Committee Co-Chair John H. Alexander, MD, MHS Highlighting Clinical Trial Progress PR Newswire ATLANTA, Nov. 19, 2020 ATLANTA , Nov. 19, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY) , a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for investors and analysts to discuss progress with the Company's...

CryoLife Reports Third Quarter 2020 Financial Results PR Newswire ATLANTA, Nov. 4, 2020 ATLANTA , Nov. 4, 2020 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Achieved total revenues of $65.1 million in the third quarter 2020 versus $67.9 million in the third quarter of 2019 Total revenues decreased 4% on a GAAP and non-GAAP constant currency basis versus third quarter 2019 Excluding TMR, third quarter revenues decreased 2% on a GAAP and non-GAAP constant currency basis versus...

CryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial Results PR Newswire ATLANTA, Oct. 21, 2020 ATLANTA , Oct. 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 third quarter financial results will be released on Wednesday, November 4, 2020 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m....

CryoLife Acquires Ascyrus Medical Conference Call and Webcast Today, September 2, 2020 at 5:00 pm ET PR Newswire ATLANTA, Sept. 2, 2020 ATLANTA , Sept. 2, 2020 /PRNewswire/ -- CryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has acquired Ascyrus Medical LLC (Ascyrus). Ascyrus is a Florida -based, privately-held developer of the Ascyrus Medical Dissection Stent (AMDS™), the world's first aortic arch...